💡Call for proposals! The UK Association for Studies in Innovation, Science and Technology (AsSIST-UK) will be hosting its 2023 in-person conference in September 2023. Deadline extended 2 June 2023 More info : https://assistuk.org/biennial-conference/
The Committee of Ministers of the Council of Europe has adopted a recommendation encouraging member states to harmonise the collection of data on the availability and use of tissues and cells according to a predefined...
For more info: https://www.edqm.eu/en/-/edqm-publishes-booklet-on-human-tissue-donation
The Council of Europe/EDQM and the European Union concluded an agreement expanding the scope of their co-operation in the field of substances of human origin. More info: https://www.edqm.eu/en/-/the-council-of-europe/edqm-and-the-european-union-conclude-an-agreement-expanding-the-scope-of-their-co-operation-in-the-field-of-substances-of-human-origin
t its 174th session in November 2022, the European Pharmacopoeia (Ph. Eur.) Commission decided to create a new Working Party on High Throughput Sequencing (HTS). Read more: https://www.edqm.eu/en/-/ph.-eur.-commission-establishes-a-dedicated-working-party-on-high-throughput-sequencing
The Committee of Ministers adopted on 1 February 2023 a Recommendation to promote, in the 46 Council of Europe member states, equitable access to medicinal products and medical equipment in a situation of shortage and to...
The Steering Committee for Human Rights in the fields of Biomedicine and Health (CDBIO)* has achieved the final step of the re-examination process of Article 13 of the Convention on Human Rights and Biomedicine with the...
The Grand Chamber of the Court of Justice of the European Union released a new judgment of 7 February 2023 on the case of Confédération paysanne and Others (In vitro random mutagenesis), C-688/21, about the...
WHO/Europe is working with countries across the European Region to develop a new multistakeholder platform to improve access to novel, high-cost medicines in the Region. Read the press release from 25 January 2023.
EDQM’s Committee on Organ Transplantation of the Council of Europe adopted a position statement in November 2022 on the Risk of commodification of substances of human origin.
